Drug Shortage Report for AURO-CEPHALEXIN
Report ID | 199587 |
Drug Identification Number | 02497751 |
Brand name | AURO-CEPHALEXIN |
Common or Proper name | CEPHALEXIN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CEPHALEXIN |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 100ML |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-07-21 |
Estimated end date | 2023-08-31 |
Actual end date | 2023-10-01 |
Shortage status | Resolved |
Updated date | 2023-10-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-07-21 | English | Compare |
v2 | 2023-07-21 | French | Compare |
v3 | 2023-07-22 | English | Compare |
v4 | 2023-08-29 | English | Compare |
v5 | 2023-08-29 | French | Compare |
v6 | 2023-10-02 | English | Compare |
Showing 1 to 6 of 6